L Perusse, T Rankinen, A Zuberi, YC Chagnon … - Obesity research, 2005 - informatik.hu-berlin.de Abstract PE´ RUSSE, LOUIS, TUOMO RANKINEN, AAMIR ZUBERI, YVON C. CHAGNON, S.
JOHN WEISNAGEL, GEORGE ARGYROPOULOS, BRANDON WALTS, ERIC E. SNYDER, AND CLAUDE
BOUCHARD. The human obesity gene map: the 2004 update. Obes Res. 2005; ... Cited by 210 - Related articles - View as HTML - All 6 versions
- ►shouxi.net D Scarpelli, M Cardellini, F Andreozzi, E … - Diabetes, 2006 - Am Diabetes Assoc Interleukin (IL)-10 is a major anti-inflammatory cytokine that has been
associated with obesity and type 2 diabetes. The three polymorphisms −1082G/A,
−819C/T, and −592C/A in the IL10 promoter were reported to influence ... Cited by 15 - Related articles - BL Direct - All 5 versions
C Stevenson, I Barroso, N Wareham - Nutritional genomics: impact on health and disease, 2006 - books.google.com 223 13 The Genetics of Type 2 Diabetes Catherine Stevenson, Ines Barroso, and
Nicholas Wareham 13.1 Evidence for Genetic Factors This chapter describes the
evidence supporting the notion that type 2 diabetes is caused, at least in ... Cited by 5 - Related articles - All 3 versions
O Spigset - Tidsskr Nor Lægeforen, 2006 - tidsskriftet.no Denne siden kan bare vises ordentlig ved bruk av javascript. Vi beklager. ...
Skreddersydd legemiddelbehandling – hvor nær målet er vi? ... Skreddersydd
legemiddelbehandling – hvor nær målet er vi? ... Bakgrunn. De senere ... Cited by 6 - Related articles - Cached - All 4 versions
MA Pacanowski, CW Hopley, CL Aquilante - Expert Opin. Drug Metab. Toxicol., 2008 - informahealthcare.com Background: Numerous effective oral pharmacologic therapies are available to
treat type 2 diabetes. However, a substantial number of patients do not achieve
the expected glucose-lowering response, or may be predisposed to adverse ... Cited by 2 - Related articles - BL Direct - All 6 versions
G Sesti, ML Hribal - Current Pharmacogenomics, 2006 - ingentaconnect.com Abstract: Type 2 diabetes is a complex and heterogeneous metabolic condition
that has reached epidemic proportions, affecting more than 150 million
individuals worldwide. Maintenance of near-normal glucose control in ... Cited by 2 - Related articles - BL Direct
ML Hribal, F Tornei, A Pujol, R Menghini, D … - Journal of Cellular and Molecular Medicine, 2008 - interscience.wiley.com Molecular scanning of human insulin receptor substrate (Irs) genes revealed a
single lrs1 prevalent variant, a glycine to arginine change at codon 972
(G972R); previous in vitro studies had demonstrated that the presence of ... Cited by 2 - Related articles - All 2 versions
ER Pearson - Current Diabetes Reports, 2009 - Springer Genetic variation can impact on efficacy and risk of adverse events to commonly
used oral agents in diabetes. Metformin is not metabolized and its mech- anism
of action remains debated; however, several cation transporters have been ... Cited by 1 - Related articles - All 2 versions
